This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which is a fusion of HIV antigens comprising at least four HIV antigens or immunogenic fragments or derivatives, wherein the four antigens or fragments are or are derived from Nef, Pol and Gag.